Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03694262
Title The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) (EndoBARR)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Medical College of Wisconsin
Indications

endometrial squamous cell carcinoma

endometrial clear cell adenocarcinoma

endometrial transitional cell carcinoma

endometrial adenocarcinoma

endometrial serous adenocarcinoma

endometrial mucinous adenocarcinoma

uterine carcinosarcoma

Therapies

Atezolizumab + Bevacizumab + Rucaparib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.